{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:06:53Z","timestamp":1789200413351,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020218","name":"Chiesi USA Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020218","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymgmr.2026.101351","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:20:34Z","timestamp":1788466834000},"page":"101351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Changes in motor function, quality of life, and clinical manifestations in patients with Alpha-mannosidosis treated with Velmanase Alfa: Data from the French \u00c9toile Alpha registry"],"prefix":"10.1016","volume":"48","author":[{"given":"Nathalie","family":"Guffon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Mention-Mulliez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Gaches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Garavaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Salomone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"H\u00e9ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymgmr.2026.101351_bb0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10545-013-9622-2","article-title":"The natural course and complications of alpha-mannosidosis\u2014a retrospective and descriptive study","volume":"37","author":"Malm","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgmr.2026.101351_bb0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10545-010-9093-7","article-title":"The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations","volume":"33","author":"Poupetova","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2026.101351_bb0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13023-015-0286-x","article-title":"Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation","volume":"10","author":"Borgwardt","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101351_bb0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-3-21","article-title":"Alpha-mannosidosis","volume":"3","author":"Malm","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101351_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108444","article-title":"Diagnosis of alpha-Mannosidosis: practical approaches to reducing diagnostic delays in this ultra-rare disease","volume":"142","author":"Santoro","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2026.101351_bb0030","series-title":"GeneReviews((R))","article-title":"Alpha-Mannosidosis","author":"Ficicioglu","year":"1993"},{"issue":"4","key":"10.1016\/j.ymgmr.2026.101351_bb0035","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ymgme.2019.01.024","article-title":"Recognition of alpha-mannosidosis in paediatric and adult patients: presentation of a diagnostic algorithm from an international working group","volume":"126","author":"Guffon","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101351_bb0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymgme.2020.04.001","article-title":"Alpha-mannosidosis - an underdiagnosed lysosomal storage disease in individuals with an \u2018MPS-like\u2019 phenotype","volume":"130","author":"Wiesinger","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101351_bb0045","first-page":"44","article-title":"Intellectual functioning in alpha-mannosidosis","volume":"50","author":"Cathey","year":"2019","journal-title":"JIMD Rep"},{"issue":"9","key":"10.1016\/j.ymgmr.2026.101351_bb0050","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1097\/JS9.0000000000000528","article-title":"Can velmanase alfa be the next widespread potential therapy for alpha-mannosidosis?","volume":"109","author":"Abdul Ghani","year":"2023","journal-title":"Int. J. Surg."},{"issue":"3","key":"10.1016\/j.ymgmr.2026.101351_bb0055","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/bmt.2011.99","article-title":"Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients","volume":"47","author":"Mynarek","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgmr.2026.101351_bb0060","author":"European Medicines Agency"},{"key":"10.1016\/j.ymgmr.2026.101351_bb0065","author":"US Food and Drug Administration"},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101351_bb0070","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10545-018-0185-0","article-title":"Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial","volume":"41","author":"Borgwardt","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101351_bb0075","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s10545-018-0175-2","article-title":"Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis","volume":"41","author":"Lund","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101351_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12799","article-title":"Extended long-term efficacy and safety of velmanase alfa treatment up to 12 years in patients with alpha-mannosidosis","volume":"48","author":"Guffon","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgmr.2026.101351_bb0085","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/ijms19051500","article-title":"Alpha-Mannosidosis: therapeutic strategies","volume":"19","author":"Ceccarini","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101351_bb0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13023-024-03146-5","article-title":"Rare disease clinical trials in the European Union: navigating regulatory and clinical challenges","volume":"19","author":"Mishra","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101351_bb0095","article-title":"Delayed diagnosis and clinical course of alpha-mannosidosis: a retrospective study of 25 patients with varying severity","volume":"3","author":"Nurse","year":"2025","journal-title":"Genet Med Open"},{"issue":"8","key":"10.1016\/j.ymgmr.2026.101351_bb0100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s003810050416","article-title":"Neurological impairment in \u03b1-mannosidosis: a longitudinal clinical and MRI study of a brother and sister","volume":"15","author":"Ara","year":"1999","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.ymgmr.2026.101351_bb0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1750-1172-8-88","article-title":"Natural history of alpha mannosidosis a longitudinal study","volume":"8","author":"Beck","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"18","key":"10.1016\/j.ymgmr.2026.101351_bb0110","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/hmg\/ddh220","article-title":"Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: a preclinical animal study","volume":"13","author":"Roces","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgmr.2026.101351_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2024.104927","article-title":"Long-term clinical evaluation of patients with alpha-mannosidosis - a multicenter study","volume":"68","author":"Kose","year":"2024","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ymgmr.2026.101351_bb0120","doi-asserted-by":"crossref","DOI":"10.1177\/2326409818796854","article-title":"Health related quality of life, disability, and pain in alpha mannosidosis: long-term data of enzyme replacement therapy with Velmanase alfa (human recombinant alpha mannosidase)","volume":"6","author":"Borgwardt","year":"2018","journal-title":"J. Inborn Errors Metab. Screen."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426926000637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426926000637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:49:25Z","timestamp":1789199365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426926000637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":24,"alternative-id":["S2214426926000637"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101351","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in motor function, quality of life, and clinical manifestations in patients with Alpha-mannosidosis treated with Velmanase Alfa: Data from the French \u00c9toile Alpha registry","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101351"}}